NTRA240517P110000
- 6.25
- 0.000.00%
Natera Newsroom
Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera's management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on
Natera Announces New MRD Data in Multiple Tumor Types, to Be Presented at ASCO Annual Meeting
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical Oncology
Form 144 | Natera(NTRA.US) Director Proposes to Sell 19.7 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 20, $Natera(NTRA.US)$ Director RMDM TRUST U/A DTD 07/31/2020 intends to sell 185K shares of its common stock on May 20, with a total market value of approximately $19.7 mil
Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Natera(NTRA.US) Officer Sells US$725.91K in Common Stock
$Natera(NTRA.US)$ Officer Chapman Steven Leonard sold 6,779 shares of common stock on May 15, 2024 at an average price of $107.0823 for a total value of $725.91K.Source: Announcement What is statement
Form 144 | Natera(NTRA.US) Officer Proposes to Sell 725.91K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Natera(NTRA.US)$ Officer STEVEN L CHAPMAN intends to sell 6,779 shares of its common stock on May 15, with a total market value of approximately $725.91K. STEVEN L C
Duquesne Family Office Top Q1 Buys, Cuts: Coherent, Eli Lilly, Others
Express News | Natera Inc : Stephens Raises Target Price to $125 From $104
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Dynavax (DVAX) and Natera (NTRA)
Planet Fitness To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Roth MKM cu
Natera Price Target Raised to $120.00/Share From $110.00 by Piper Sandler
Natera Price Target Raised to $120.00/Share From $110.00 by Piper Sandler
Natera Is Maintained at Overweight by Piper Sandler
Natera Is Maintained at Overweight by Piper Sandler
Express News | Piper Sandler Maintains Overweight on Natera, Raises Price Target to $120
Analysts' Top Healthcare Picks: Oculis Holding (OCS), Natera (NTRA)
Key Takeaways From Natera Analyst Ratings
11 analysts have shared their evaluations of Natera (NASDAQ:NTRA) during the recent three months, expressing a mix of bullish and bearish perspectives.The following table summarizes their recent ratin
Natera Is Maintained at Buy by BTIG
Natera Is Maintained at Buy by BTIG
Express News | BTIG Maintains Buy on Natera, Raises Price Target to $125
Natera Insider Sold Shares Worth $3,137,567, According to a Recent SEC Filing
Daniel Rabinowitz, Secretary and Chief Legal Officer, on May 10, 2024, sold 30,000 shares in Natera (NTRA) for $3,137,567. Following the Form 4 filing with the SEC, Rabinowitz has control over a total
Express News | Natera Inc : Btig Raises Target Price to $125 From $100
Decoding Natera Inc (NTRA): A Strategic SWOT Insight